Cognitive Behavioral Therapy, Guided Self Help Versus Individual Therapy
1 other identifier
interventional
396
1 country
1
Brief Summary
Background: Studies show that about 1 out of 3 patients in Primary Care suffer primarily from mental health disorders, such as anxiety disorders and depression. Cognitive behavior therapy (CBT) has been shown to be an effective treatment of these disorders. Despite the strong evidence for CBT there is a lack of evidence-based psychological treatment in primary care. For various reasons, the progress of research has not affected clinical practice. For successful implementation of CBT in primary care cost-effective therapies, access to therapists with proper training and supervision, evidence-based manuals and management that support the implementation is needed. Aim: The aim of this trial is to evaluate a stepped care model with CBT in primary care. All patients are first treated with self-help CBT (N = 400). Patients that do not improve after treatment (9 weeks) are randomized to individual CBT or continued self-help treatment. Based on published studies 2/3 is expected to be improved after self-help and therefore do not undergo randomization. 1/3 (n = 133) who didn´t respond to treatment is randomized to individual CBT (N = 67) or continued self-help treatment (N = 67).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Aug 2012
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 10, 2012
CompletedFirst Posted
Study publicly available on registry
August 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedOctober 18, 2016
October 1, 2016
3.3 years
August 10, 2012
October 14, 2016
Conditions
Outcome Measures
Primary Outcomes (4)
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
Absolute improvement, i.e., symptom level below pre-established cut-offs at 9 weeks, 20 weeks, 26 week follow-up, and 52 week follow-up compared to baseline.
9 weeks
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
20 weeks
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
26 weeks
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
Absolute improvement in disorder specific symptoms defined as closer to healthy than to clinical population or 2 standard deviations from clinical population
52 weeks
Secondary Outcomes (14)
Montgomery-Åsberg Depression Rating Scale-Self-report (MADRS-S)
Baseline, post-treatment (20 weeks), 26 week follow-up, 52 week follow-up
Work ability index (WAI)
Baseline, post-treatment (20 weeks), 26 week follow-up, 52 week follow-up
Insomnia Severity Index (ISI)
Baseline, post-treatment (20 weeks), 26 week follow-up, 52 week follow-up
Health Anxiety Inventory (HAI)
Baseline, post-treatment (20 weeks), 26 week follow-up, 52 week follow-up
Perceived Stress Scale (PSS)
Baseline, post-treatment (20 weeks), 26 week follow-up, 52 week follow-up
- +9 more secondary outcomes
Other Outcomes (1)
Inflammatory cytokines
Baseline, post-treatment (20 weeks)
Study Arms (2)
Continued guided self help CBT
ACTIVE COMPARATORContinued guided self help CBT. Participants will receive CBT through self-help books with minimal therapist contact (3 sessions in total).
CBT individual therapy
EXPERIMENTALAfter the initial face of self help CBT, patients in this arm receive individual CBT. The cognitive behavior therapy used in the study will be based on the protocols with best empirical support.The therapy is delivered by the same psychologist as in the first face and the second face builds on the learning's from the first face.
Interventions
After the initial Guided self help, patients in this arm continue the same self help program with 1 additional guiding session.
After the initial face of self help CBT, patients in this arm receive individual CBT. The cognitive behavior therapy used in the study will be based on the protocols with best empirical support.The therapy is delivered by the same psychologist as in the first face and the second face builds on the learning's from the first face.
Eligibility Criteria
You may qualify if:
- Have an anxiety disorder diagnosis (obsessive compulsive disorder, social phobia, panic disorder, generalized anxiety disorder), or/and major depression, or/and maladaptive stress reaction, or/and primary insomnia Clinician severity rating scale 2-6
You may not qualify if:
- A higher score than 6 on the Clinician severity rating scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
Study Sites (1)
Karolinska Institutet and Gustavsberg primary care center
Stockholm, Stockholm County, 13440, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 10, 2012
First Posted
August 17, 2012
Study Start
August 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
October 18, 2016
Record last verified: 2016-10